共 37 条
[1]
Dhalla K.S., Rupp H., Beamish R.E., Dhalla N.S., Mechanisms of alterations in cardiac membrane Ca<sup>2+</sup> transport due to excess catecholamines, Cardiovasc. Drugs. Ther., 10, pp. 231-238, (1996)
[2]
Rupp H., Dhalla K.S., Dhalla N.S., Mechanisms of cardiac cell damage due to catecholamines: Significance of drugs regulating central sympathetic outflow, J. Cardiovasc. Pharmacol., 24, 1 SUPPL., (1994)
[3]
Hoffman B.B., Lefkowitz R.J., Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists, in Goodman & Gilman's, The Pharmacological Basis of Therapeutics, pp. 199-248, (1996)
[4]
Dhalla N.S., Yates J.C., Naimark B., Dhalla K.S., Beamish R.E., Ostadal B., Cardiotoxicity of catecholamines and related agents, Cardiovascular Toxicity, pp. 239-281, (1992)
[5]
Ramos K., Acosta D., Cytotoxic actions of isoproterenol in cardiac cells: Protective effects of antioxidants, CRC Handbook of Free Radicals and Antioxidants in Biomedicine, pp. 177-185, (1989)
[6]
Bindoli A., Rigobello M.P., Galzigna L., Toxicity of aminochromes, Toxicol. Lett., 48, pp. 3-20, (1989)
[7]
Bindoli A., Rigobello M.P., Deeble D.J., Biochemical and toxicological properties of the oxidation products of catecholamines, Free Radic. Biol. Med., 13, pp. 391-405, (1992)
[8]
Remiao F., Carmo H., Carvalho F., Bastos M.L., Inhibition of glutathione reductase by isoproterenol oxidation products, J. Enzym. Inhib., 15, pp. 47-61, (1999)
[9]
Taam G.M., Takeo S., Ziegelhoffer A., Singal P.K., Beamish R.E., Dhalla N.S., Effect of adrenochrome on adenine nucleotides and mitochondrial oxidative phosphorylation in rat heart, Can. J. Cardiol., 2, 2, pp. 88-93, (1986)
[10]
Remiao F., Carmo H., Carvalho F., Bastos M.L., Cardiotoxicity studies using freshly isolated calcium-tolerant cardiomyocytes from adult rat, In Vitro Cell Dev. Biol. Anim., 37, pp. 1-4, (2001)